Abstract
THIRTEEN years after its discovery1, there is still controversy over the chemical identity of endothelium-derived relaxing factor (EDRF). Although pharmacological and chemical evidence indicates that EDRF is nitric oxide2, other candidates, including S-nitrosocysteine3,4, dinitrosyl–iron–cysteine complex5, nitroxyl6 and hydroxylamine7, have been proposed to account for the vasorelaxant properties of EDRF. Such diverse compounds should differ in their stability and in reactivity with oxhaemoglobin and with redox-active nucleophiles such as thiols. Here we use a bioassay to compare the pharmacodynamic profiles of these and other compounds with those of nitric oxide and EDRF. We find that some S-nitrosothiols, dinitrosyl–iron–cysteine complex, sodium nitroxyl and hydroxylamine can be eliminated as candidates as they are more stable than EDRF and less susceptible to inhibition by oxyhaemoglobin. Co-infusion of cysteine revealed major differences between the remaining candidates because it reduced the effect of authentic nitric oxide and EDRF on the bioassay tissues but enhanced the survival of S-nitrosocysteine and S-nitroso-cysteamine. Our results further support the evidence that EDRF, the pharmacological entity described by Furchgott and Zawadzki1, is nitric oxide.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Furchgott, R. F. & Zawadzki, J. V. Nature 288, 373–376 (1980).
Palmer, R. M. J., Ferrige, A. G. & Moncada, S. Nature 327, 524–526 (1987).
Myers, P. R., Minor, R. L. Jr, Guerra, R. Jr, Bates, J. & Harrison, D. G. Nature 345, 161–163 (1990).
Rubanyi, G. M., Johns, A., Harrison, D. & Wilcox, D. Circulation (suppl.) 80, 11–281 (abstr.) (1988).
Vanin, A. F. FEBS LETT. 289, 1–3 (1991).
Fukuto, J. M., Hszieh, R. & Chiang, K. T. FASEB J. 6, A972 (abstr.) (1992).
Thomas, G. & Ramwell, P. W. Biochem. biophys. Res. Commun. 164, 889–893 (1989).
Palmer, R. M. J., Ferrige, A. G. & Moncada, S. Nature 327, 524–526 (1987).
Lewis, S. J. et al. FASEB J. 6, A1165 (abstr.) (1992).
Flitney, F. W., Megson, I. L., Flitney, D. E. & Butler, A. R. Br. J. Pharmac. 107, 842–848 (1992).
Furchgott, R. F., Jothianandan, D. & Khan, M. T. Jpn. J. Pharmac. 58, (Suppl. 2), 185P–191P (1992).
Stamler, J. S. et al. Proc. natn. Acad. Sci. U.S.A. 89, 444–448 (1992).
Misra, H. P. J. biol. Chem. 269, 2151–2155 (1974).
Moncada, S., Palmer, R. M. J. & Gryglewski, R. J. Proc. natn. Acad. Sci. U.S.A. 83, 9164–9168 (1986).
Zamora Pino, R. & Feelisch, M. Endothelium 1, S69 (abstr.) (1993).
Fukuto, J. M., Chiang, K., Hszieh, R., Wong, P. & Chaudhuri, G. J. Pharmac. exp. Ther. 263, 546–551 (1992).
McAninly, J., Williams, D. L. H., Askew, S. C., Butler, A. R. & Russell, C. JCS chem. Commun. 23, 1758–1759 (1993).
Jocelyn, P. C. Biochemistry of the SH Group (Academic, New York, 1972).
Feelisch, M. J. cardiovasc. Pharmac. 17, S25–S33 (1991).
Vedernikov, Y. P., Mordvintcev, P. I., Maienkova, I. V. & Vanin, A. F. Eur. J. Pharmac. 221, 313–317 (1992).
Zintl, E. & Harder, A. Chem. Ber. 66, 760–761 (1933).
Kelm, M. et al. Biochem. biophys. Res. Commun. 154, 236–244 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feelisch, M., te Poel, M., Zamora, R. et al. Understanding the controversy over the identity of EDRF. Nature 368, 62–65 (1994). https://doi.org/10.1038/368062a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/368062a0
This article is cited by
-
Synthesis of steroids containing N’-alkoxydiazene N-oxide groups
Russian Chemical Bulletin (2022)
-
Production of nitric oxide elevates nitrosothiol formation resulting in decreased glutathione in macrophages exposed to asbestos or asbestos substitutes
Archives of Toxicology (2005)
-
In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S‐nitrosylated Captopril, a nitric oxide donor
British Journal of Pharmacology (2001)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.